Announcement on Progress in Cooperation in Investment with a Private Fund
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Progress in Cooperation in Investment with a Private Fund
Filed with SSE · · 2 pages · Chinese
Release
Beijing Sun-Novo Pharmaceutical Research Co. Ltd. on 6ix
Earlier from Beijing Sun-Novo Pharmaceutical Research
- for STC008 Injection
- Announcement on Application for Comprehensive Credit Line and Estimated Amount of Guarantees by the Company and Its Subsidiaries
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of ABA001 Injection
- Announcement on Postponing Term Change of the Board of Directors and Resignation upon Term Expiration of Partial Independent Directors
- Announcement on the Self-Inspection Report on Insider Trading During the Self-Inspection Period by Persons Aware of Material Non-public Information Related to the Termination of Issuance of Shares and Convertible Corporate Bonds to Acquire Assets, Raising Supporting Funds, and Related Party Transactions
Later from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Completion of the Board of Directors' Re-election, Election of the Chairman and Members of Special Committees under the Board of Directors, and Appointment of Senior Management Member and Securities Affairs Representative
- Announcement on Voluntary Disclosure on the Acceptance of Clinical Trial Application for STC009 Injection
- Announcement on Progress in Signing of the "Supplementary Agreement to the Technology Development Contract" for STC008 Injection
- Announcement on Participation in the Establishment of Hangzhou Qizhen Zhikang Equity Investment Partnership (Limited Partnership)
- Announcement on Implementation of Dividend Distribution for 2025
Follow Beijing Sun-Novo Pharmaceutical Research into a list and get an email when it puts out news.
Follow Beijing Sun-Novo Pharmaceutical Research